Brussels, 17/07/2007 (Agence Europe) - Born of real need - to develop medicines tailored for poor countries - and institutional concern - the first use of Article 169 of the Treaty - the European and Developing Countries Trials Partnership (EDCTP) has been far from delivering the expected results. That was what a panel of five independent experts found, and their recommendation is for significant amendments to the management structure of the programme. There was one dissenting voice from...